Comparison of combined oral contraceptive Yasmin and Cyproteron compound on Hirsutism and androgens in women with a polycystic ovary syndrome
Phase 3
- Conditions
- Condition 1: Polycystic ovarian syndrome. Condition 2: Hirsutism.Polycystic ovarian syndromeHypertrichosis
- Registration Number
- IRCT201104251760N13
- Lead Sponsor
- Vice Chancellor for Research and Technology, Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
18-28 years old nonsmoker women with polycystic ovary syndrome and Hirsutism who are raftered to our research center for treatment of Hirsutism and taking contraceptive necessities. Exclusion criteria: Hyper-prolactinemia; Hypothyroidism; diabetes; doing regular intense exercise; taking diet or herbal treatment, Non-steroidal anti- inflammatory drugs, diuretics, or hormone therapy during last 3 months.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Back spontaneous menstrual. Timepoint: 6 months after cessation of treatment. Method of measurement: Clinical examination.
- Secondary Outcome Measures
Name Time Method Side effects of drugs (such as complaints of headaches and spotting). Timepoint: 4 months. Method of measurement: Clinical examination.